Comparative Pharmacology
Head-to-head clinical analysis: AMINOSYN PF 10 versus AMINOSYN PF 7.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMINOSYN PF 10 versus AMINOSYN PF 7.
AMINOSYN-PF 10% vs AMINOSYN-PF 7%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminosyn-PF 10% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in neonates and pediatric patients.
Aminosyn-PF 7% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, thereby maintaining nitrogen balance and supporting tissue repair and growth in parenteral nutrition.
Intravenous infusion: 1-1.5 g amino acids/kg/day (protein equivalent) as part of total parenteral nutrition. Typical rate: 0.5-2.0 mL/kg/hour initially, titrated to metabolic needs.
Intravenous infusion; typical adult dose: 1-2 g amino acids/kg/day (e.g., 14-28 mL/kg/day for 7% solution) as part of parenteral nutrition. Infusion rate not to exceed 0.1 g amino acids/kg/hour.
None Documented
None Documented
Variable; amino acids have half-lives of minutes to hours; clinical context: continuous infusion maintains steady state
As a mixture of amino acids, individual amino acids have half-lives ranging from minutes to hours; clinically, continuous infusion maintains steady state.
Renal: >90% as amino acids and metabolites; <10% fecal/biliary
Amino acids are primarily cleared by metabolism; less than 10% is excreted unchanged in urine.
Category C
Category C
Parenteral Nutrition Solution
Parenteral Nutrition Solution